Linked Life Data

10416005

Source:http://linkedlifedata.com/resource/pubmed/id/10416005

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10416005rdf:typepubmed:Citationlld:pubmed
pubmed-article:10416005lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10416005lifeskim:mentionsumls-concept:C0278488lld:lifeskim
pubmed-article:10416005lifeskim:mentionsumls-concept:C0013089lld:lifeskim
pubmed-article:10416005lifeskim:mentionsumls-concept:C0246415lld:lifeskim
pubmed-article:10416005lifeskim:mentionsumls-concept:C1708063lld:lifeskim
pubmed-article:10416005lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:10416005pubmed:issue5lld:pubmed
pubmed-article:10416005pubmed:dateCreated1999-9-2lld:pubmed
pubmed-article:10416005pubmed:abstractTextTo determine the maximum tolerated dose (MTD), the dose-limiting toxicity (DLT) and the recommended dose of docetaxel in combination with doxorubicin, and to evaluate the activity in patients with advanced breast cancer.lld:pubmed
pubmed-article:10416005pubmed:languageenglld:pubmed
pubmed-article:10416005pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10416005pubmed:citationSubsetIMlld:pubmed
pubmed-article:10416005pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10416005pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10416005pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10416005pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10416005pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10416005pubmed:statusMEDLINElld:pubmed
pubmed-article:10416005pubmed:monthMaylld:pubmed
pubmed-article:10416005pubmed:issn0923-7534lld:pubmed
pubmed-article:10416005pubmed:authorpubmed-author:PouillartPPlld:pubmed
pubmed-article:10416005pubmed:authorpubmed-author:RivaAAlld:pubmed
pubmed-article:10416005pubmed:authorpubmed-author:JasminCClld:pubmed
pubmed-article:10416005pubmed:authorpubmed-author:MissetJ LJLlld:pubmed
pubmed-article:10416005pubmed:authorpubmed-author:CvitkovicEElld:pubmed
pubmed-article:10416005pubmed:authorpubmed-author:BourgeoisHHlld:pubmed
pubmed-article:10416005pubmed:authorpubmed-author:DierasVVlld:pubmed
pubmed-article:10416005pubmed:authorpubmed-author:BeuzebocPPlld:pubmed
pubmed-article:10416005pubmed:authorpubmed-author:KalleWWlld:pubmed
pubmed-article:10416005pubmed:authorpubmed-author:AzliNNlld:pubmed
pubmed-article:10416005pubmed:authorpubmed-author:AusselJ PJPlld:pubmed
pubmed-article:10416005pubmed:authorpubmed-author:BozekTTlld:pubmed
pubmed-article:10416005pubmed:authorpubmed-author:GruiaGGlld:pubmed
pubmed-article:10416005pubmed:issnTypePrintlld:pubmed
pubmed-article:10416005pubmed:volume10lld:pubmed
pubmed-article:10416005pubmed:ownerNLMlld:pubmed
pubmed-article:10416005pubmed:authorsCompleteYlld:pubmed
pubmed-article:10416005pubmed:pagination553-60lld:pubmed
pubmed-article:10416005pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:10416005pubmed:meshHeadingpubmed-meshheading:10416005...lld:pubmed
pubmed-article:10416005pubmed:meshHeadingpubmed-meshheading:10416005...lld:pubmed
pubmed-article:10416005pubmed:meshHeadingpubmed-meshheading:10416005...lld:pubmed
pubmed-article:10416005pubmed:meshHeadingpubmed-meshheading:10416005...lld:pubmed
pubmed-article:10416005pubmed:meshHeadingpubmed-meshheading:10416005...lld:pubmed
pubmed-article:10416005pubmed:meshHeadingpubmed-meshheading:10416005...lld:pubmed
pubmed-article:10416005pubmed:meshHeadingpubmed-meshheading:10416005...lld:pubmed
pubmed-article:10416005pubmed:meshHeadingpubmed-meshheading:10416005...lld:pubmed
pubmed-article:10416005pubmed:meshHeadingpubmed-meshheading:10416005...lld:pubmed
pubmed-article:10416005pubmed:meshHeadingpubmed-meshheading:10416005...lld:pubmed
pubmed-article:10416005pubmed:meshHeadingpubmed-meshheading:10416005...lld:pubmed
pubmed-article:10416005pubmed:meshHeadingpubmed-meshheading:10416005...lld:pubmed
pubmed-article:10416005pubmed:meshHeadingpubmed-meshheading:10416005...lld:pubmed
pubmed-article:10416005pubmed:year1999lld:pubmed
pubmed-article:10416005pubmed:articleTitleDose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer.lld:pubmed
pubmed-article:10416005pubmed:affiliationHôpital Paul Brousse, Villejuif, France. jean-louis.misset@pbr.ap-hop-paris.frlld:pubmed
pubmed-article:10416005pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10416005pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10416005pubmed:publicationTypeClinical Trial, Phase Illd:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10416005lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10416005lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10416005lld:pubmed